At the conclusion of this activity, learners should be able to:

  • Understand the role of EGFR in lung cancer
  • Know the discovery of EGFR mutations in NSCLC
  • Recognize secondary and tertiary EGFR mutations
  • Distinguish small cell transformation
  • Introduce the pathology workflow for the EGFR-mutant NSCLC


Session date: 
10/01/2021 - 12:00pm to 1:00pm EDT

Please login or register to take this course.
Room Number: 
Zoom Meeting
Speaker Name: 
Weiwei Shi, MD, PhD